Trinity Biotech plc (NASDAQ:TRIB) Short Interest Update

Trinity Biotech plc (NASDAQ:TRIB) saw a significant drop in short interest in the month of February. As of February 15th, there was short interest totalling 396,900 shares, a drop of 33.5% from the January 31st total of 596,800 shares. Based on an average trading volume of 2,090,000 shares, the days-to-cover ratio is presently 0.2 days. Currently, 3.6% of the shares of the stock are short sold.

Analyst Ratings Changes

Separately, StockNews.com began coverage on Trinity Biotech in a report on Wednesday. They issued a “hold” rating for the company.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Trinity Biotech stock. Hunter Associates Investment Management LLC grew its position in Trinity Biotech plc (NASDAQ:TRIB) by 5.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 378,590 shares of the company’s stock after buying an additional 18,780 shares during the quarter. Hunter Associates Investment Management LLC’s holdings in Trinity Biotech were worth $334,000 at the end of the most recent quarter. 78.97% of the stock is currently owned by hedge funds and other institutional investors.

Trinity Biotech Stock Down 2.9 %

Shares of TRIB stock opened at $0.73 on Friday. Trinity Biotech has a fifty-two week low of $0.72 and a fifty-two week high of $3.55. The stock has a market cap of $13.20 million, a P/E ratio of -0.32 and a beta of 1.03. The business has a fifty day simple moving average of $0.85 and a 200-day simple moving average of $1.29.

Trinity Biotech Company Profile

Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas and Ireland. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes.